Transdermal and Oral Extended Release Opioid Analgesic Treatment Options for Moderate to Severe Chronic Pain
Sponsored by Purdue Pharma L.P.
This activity is not certified for credit.
Date
Thursday, September 8, 2011
Start Time
8:30 am
End Time
9:30 am
Room
Mont-Royal Ballroom
Level 4
Program Description
Join your colleagues to hear Dr. Michael Brennan discuss considerations for appropriate use and prescribing of selected transdermal and oral extended-release opioid analgesics in the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid for an extended period of time.
Faculty
Michael J. Brennan, MD
The Pain Center of Fairfield, Fairfield, CT
Senior Attending Physician
Department of Medicine, Physical Medicine, and Rehabilitation
Bridgeport Hospital
Bridgeport, Connecticut
Registration
No preregistration required. First come, first served.
Contact Name
Alexandra Martinez
Contact Phone
(203) 588-7311
- Pathophysiology of Pain: Mechanisms and Manifestations
- Responsible Opioid Prescribing in the Era of REMS
- Risk Mitigation in Reality: Best Practices from a Transmucosal Fentanyl REMS
- Persistent and Breakthrough Cancer Pain
- Chronic Pain: Best Practices in Interdisciplinary Multimodal Management
